BYLENCYA Trademark

Trademark Overview


On Friday, March 20, 2015, a trademark application was filed for BYLENCYA with the United States Patent and Trademark Office. The USPTO has given the BYLENCYA trademark a serial number of 86570710. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 24, 2018. This trademark is owned by Novartis AG. The BYLENCYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
bylencya

General Information


Serial Number86570710
Word MarkBYLENCYA
Filing DateFriday, March 20, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 24, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 30, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, September 24, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 24, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, March 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 1, 2018EXTENSION 5 GRANTED
Monday, February 19, 2018EXTENSION 5 FILED
Monday, February 19, 2018TEAS EXTENSION RECEIVED
Wednesday, August 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2017EXTENSION 4 GRANTED
Monday, August 14, 2017EXTENSION 4 FILED
Monday, August 14, 2017TEAS EXTENSION RECEIVED
Saturday, February 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 16, 2017EXTENSION 3 GRANTED
Thursday, February 16, 2017EXTENSION 3 FILED
Thursday, February 16, 2017TEAS EXTENSION RECEIVED
Tuesday, September 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 10, 2016EXTENSION 2 GRANTED
Wednesday, August 17, 2016EXTENSION 2 FILED
Friday, September 9, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 17, 2016TEAS EXTENSION RECEIVED
Thursday, February 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 16, 2016EXTENSION 1 GRANTED
Tuesday, February 16, 2016EXTENSION 1 FILED
Tuesday, February 16, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 15, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 13, 2015ASSIGNED TO LIE
Tuesday, April 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 20, 2015ASSIGNED TO EXAMINER
Monday, March 30, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 24, 2015NEW APPLICATION ENTERED IN TRAM